Acro Biomedical Co., Ltd.
ACBM
$0.105
$0.000.00%
| Weiss Ratings | ACBM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | ACBM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ACBM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.85 | |||
| Price History | ACBM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -97.49% | |||
| 2-Year Total Return | -97.56% | |||
| 3-Year Total Return | -96.91% | |||
| 5-Year Total Return | -97.74% | |||
| 52-Week High % Change | -96.72% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | ACBM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $4.20 | |||
| 52-Week Low Price | $0.11 | |||
| 52-Week Low Price (Date) | Oct 31, 2023 | |||
| 52-Week High Price (Date) | Apr 13, 2023 | |||
| Valuation | ACBM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 6.30M | |||
| Enterprise Value | 6.39M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.25 | |||
| Earnings Per Share Growth | 1.41% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 18.75 | |||
| Price/Book (Q) | 18.42 | |||
| Enterprise Value/Revenue (TTM) | 17.76 | |||
| Price | $0.11 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -0.42 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ACBM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 63.91M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ACBM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 317 286 6788 | |||
| Address | 12175 Visionary Way Fishers, IN 46038 | |||
| Website | acrobiomedicalco.com | |||
| Country | United States | |||
| Year Founded | 2014 | |||
| Profitability | ACBM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -4,206.38% | |||
| Profit Margin | -4,207.19% | |||
| Management Effectiveness | ACBM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -1,566.43% | |||
| Return on Equity | -- | |||
| Income Statement | ACBM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 360.00K | |||
| Total Revenue (TTM) | 360.00K | |||
| Revenue Per Share | $0.01 | |||
| Gross Profit (TTM) | 64.00K | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -15.14M | |||
| Net Income (TTM) | -15.15M | |||
| Net Income Avl. to Common (TTM) | -15.15M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 20.04% | |||
| EPS Diluted (TTM) | -0.25 | |||
| EPS Diluted Growth (Q YOY) | 20.12% | |||
| Balance Sheet | ACBM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.70K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 526.20K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 339.70K | |||
| Current Ratio (Q) | 2.638 | |||
| Book Value Per Share (Q) | $0.01 | |||
| Total Assets (Q) | 539.10K | |||
| Total Current Liabilities (Q) | 199.50K | |||
| Total Debt (Q) | 92.00K | |||
| Total Liabilities (Q) | 199.50K | |||
| Total Common Equity (Q) | 339.70K | |||
| Cash Flow | ACBM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 57.60K | |||
| Net Change in Cash (TTM) | -9.30K | |||
| Levered Free Cash Flow (TTM) | 5.61M | |||
| Cash from Operations (TTM) | -67.20K | |||
